These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Treatment of severe postmenopausal osteoporosis]. Reĭsner NA; Babarykin DA; Vorona IG; Riabukha AN; Rozental' RL Probl Endokrinol (Mosk); 1988; 34(4):13-6. PubMed ID: 3194355 [TBL] [Abstract][Full Text] [Related]
9. Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3. Massry SG; Tuma S; Dua S; Goldstein DA J Lab Clin Med; 1979 Jul; 94(1):152-7. PubMed ID: 469372 [TBL] [Abstract][Full Text] [Related]
10. [Effect of vitamin D on remaining kidney function after chronic kidney failure in preservation period patient]. Inaguma D; Tatematsu M; Shinjo H; Suzuki S; Mishima T; Inaba S; Nakamura T; Kato T Clin Calcium; 2005 Sep; 15 Suppl 1():152-5; discussion 155. PubMed ID: 16272649 [TBL] [Abstract][Full Text] [Related]
11. Changes in bone histomorphometry and bone mineral during treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium. Lindholm TS; Nilsson OS; Elmstedt E; Eriksson SA; Lindholm TC; Kyhle BR Acta Vitaminol Enzymol; 1981; 3(3):170-6. PubMed ID: 7347489 [TBL] [Abstract][Full Text] [Related]
12. Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women. Selby PL; Peacock M N Engl J Med; 1986 Jun; 314(23):1481-5. PubMed ID: 3754618 [TBL] [Abstract][Full Text] [Related]
13. The use of metabolites and analogues of vitamin D in prospective renal transplant recipients. Cundy T; Kanis JA; Fraher L; Clemens TL; O'Riordan JL Clin Nephrol; 1981 May; 15(5):240-5. PubMed ID: 7018772 [No Abstract] [Full Text] [Related]
14. [Effect of 1-alpha oxyvitamin D3 on bone tissue in systemic osteoporosis]. Rodionova SS; Zatsepin ST; Shvets VN Ortop Travmatol Protez; 1989 Feb; (2):37-40. PubMed ID: 2726218 [TBL] [Abstract][Full Text] [Related]
15. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis. Ringe JD; Faber H; Fahramand P; Schacht E J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849 [TBL] [Abstract][Full Text] [Related]
16. Some effects of ethinyl oestradiol on calcium and phosphorus metabolism in osteoporosis. Young MM; Jasani C; Smith DA; Nordin BE Clin Sci; 1968 Jun; 34(3):411-7. PubMed ID: 5666871 [No Abstract] [Full Text] [Related]
17. Preventive treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium. Evaluation of bone histomorphometry in osteoporotics and age matched controls. Lindholm TS; Nilsson OS; Widhe T; Elmsted E; Eriksson S Acta Vitaminol Enzymol; 1982; 4(1-2):179-84. PubMed ID: 7124565 [No Abstract] [Full Text] [Related]
18. Action of 1,25-dihydroxycholecalciferol in normal and uraemic man. Coburn JW; Brickman AS; Massry SG; Singer FR; Norman AW Proc Eur Dial Transplant Assoc; 1973; 10(0):210-6. PubMed ID: 4802387 [No Abstract] [Full Text] [Related]
19. [Current research in therapy of postmenopausal osteoporosis (author's transl)]. Laroche C; Detilleux M; Sereni D Sem Hop; 1979 Feb 18-25; 55(7-8):325-9. PubMed ID: 220722 [TBL] [Abstract][Full Text] [Related]
20. Calcitriol in disorders of bone and calcium metabolism. Riggs BL Clin Ther; 1980; 3(1):33-9. PubMed ID: 6893296 [No Abstract] [Full Text] [Related] [Next] [New Search]